Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00853333 · ClinicalTrials.gov registry record · NA
Sedation and Pain (The Effect of IV Sedation on Pain Perception)
A NA study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- NA
- Development phase
- 86
- Enrollment target
NCT00853333 is a NA study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 86 participants.
The verdict
NCT00853333, a NA study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- NA
- Development phase
- 86 participants
- Enrollment target
Study Summary
The investigators propose to evaluate the potential effect of sedation on pain perception in two ways, by asking for a participant's pain rating(subjective) and by evaluating a subject's brain activation using fMRI(objective).
Interventions
- DRUG midazolam
- DRUG propofol
- DRUG dexmedetomidine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 86 participants |
| Start Date | 2008-11 |
| Est. Completion | 2012-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00853333
The ClinicalTrials.gov registry entry for NCT00853333 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 86 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which midazolam is the first listed.
NCT00853333 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00853333 about?
NCT00853333 is a clinical study titled "Sedation and Pain (The Effect of IV Sedation on Pain Perception)". The investigators propose to evaluate the potential effect of sedation on pain perception in two ways, by asking for a participant's pain rating(subjective) and by evaluating a subject's brain activation using fMRI(objective).
What is the current status of trial NCT00853333?
This trial is currently completed. It is a NA study. The enrollment target is 86 participants. The study started on 2008-11. Estimated completion is 2012-01.
What interventions are being tested in trial NCT00853333?
The interventions under investigation include: midazolam (DRUG), propofol (DRUG), dexmedetomidine (DRUG).
Who is sponsoring clinical trial NCT00853333?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.